Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)

NCT03055234 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Pulmonary Hypertension Associated With Sickle Cell Disease

Interventions

DRUG: Oral Treprostinil
DRUG: Placebo

Sponsor

United Therapeutics